NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
Celgene
Rutgers, The State University of New Jersey
University of Alberta
Taipei Medical University
Inje University
University of South Florida